This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Glancy Binkow & Goldberg LLP Announces Investigation Of Centene Corporation

Stocks in this article: CNC

Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of purchasers of the securities of Centene Corporation (“Centene” or the “Company”) (NYSE:CNC) concerning possible violations of federal securities laws. The investigation focuses on allegations that certain statements issued by Centene between February 7, 2012 and June 8, 2012 were false and misleading concerning the Company’s financial performance and prospects.

Centene operates as a multiline healthcare company in the United States that provides Medicaid and Medicaid-related health plan coverage to individuals through government subsidized programs, including Medicaid, foster care and Medicare special needs plans, among others. The investigation concerns allegations that during the foregoing period the Company misrepresented or failed to disclose that: (1) Centene’s profit and revenue forecasts issued in January 2012, and increased in April 2012, were lacking in any reasonable basis; (2) at the time the Company issued its revenue forecast in January 2012, Company insiders knew that the competitive landscape in the industry was more difficult than described and would thus make the Company’s guidance impossible to achieve; (3) certain Company insiders capitalized on this material adverse information to sell Centene shares at inflated prices before the truth concerning the Company’s financial performance was disclosed to the market; (4) the Company lacked adequate internal and financial controls; and (5), as a result of the above, the Company’s statements concerning its business and operational prospects were materially false and misleading at all relevant times.

If you purchased Centene securities between February 7, 2012 and June 8, 2012, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Michael Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, by telephone at (310) 201-9150, Toll Free at (888) 773-9224, by e-mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Copyright Business Wire 2010

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,858.03 +30.28 0.17%
S&P 500 2,074.70 +1.87 0.09%
NASDAQ 4,796.2820 +8.9650 0.19%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs